Preemptive interferon-α therapy could prevent relapse of acute myeloid leukemia following allogeneic hematopoietic stem cell transplantation: A real-world analysis

INTRODUCTION: Measurable residual disease (MRD)-directed interferon-a treatment (i.e. preemptive IFN-α treatment) can eliminate the MRD in patients with acute myeloid leukemia (AML) after allogeneic hematopoietic stem cell transplantation (allo-HSCT). Therefore, this study aimed to further assess it...

Descripción completa

Detalles Bibliográficos
Autores principales: Fan, Shuang, Pan, Tian-Zhong, Dou, Li-Ping, Zhao, Yan-Min, Zhang, Xiao-Hui, Xu, Lan-Ping, Wang, Yu, Huang, Xiao-Jun, Mo, Xiao-Dong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9932895/
https://www.ncbi.nlm.nih.gov/pubmed/36817493
http://dx.doi.org/10.3389/fimmu.2023.1091014

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9932895/
https://www.ncbi.nlm.nih.gov/pubmed/36817493
http://dx.doi.org/10.3389/fimmu.2023.1091014

Ejemplares similares